User:Kachowow101/sandbox

Health Equity

Genentech has made strides in advancing inclusive research and health equity in the biotechnology industry. They consider health inequity a crisis that manifests through healthcare inequities and the underrepresentation of marginalized populations in clinical trials. In particular, Black individuals and other people of color are often represented in low numbers in clinical trials and are less likely to receive quality healthcare than white patients. Genentech invested in health equity initiatives claiming donations of $125M to national partnerships and patient-centered grants since 2017 and $21M to support inclusive research for patients of color since 2019. Genentech also co-hosts the Health Equity Symposium, a collaboration with healthcare institutions and community organizations to address inequities among diverse populations.

While investing in health equity initiatives, Genentech works internally to advance inclusive research. They describe their priorities as recruiting more diverse people in their clinical research to make outcomes more representative, including updated knowledge of clinical outcomes to their data sets and a reassessment of their standards to their inclusive research policies.

Diversity & Inclusion Efforts

Genentech has committed to promoting diversity, equity, and inclusion within its organization. They have launched initiatives aimed at increasing the representation of underrepresented groups in the workplace, promoting cultural competency, and fostering a welcoming and inclusive workplace culture. According to their most recent Diversity and Inclusion report published in 2021, Genentech's priorities for their workforce aim at increasing representation of people of color in their workforce, increasing Black/African American and Hispanic/Latinx representation in leadership, and reflecting the numbers in Asian representation in leadership in comparison to their representation in the general workforce. In addressing gender equity, their public EEO-1 reporting shows that over 50% of their workforce across all levels of management identify as female and find no pay gap among women compared to men in their pay gap analysis.

In 2022, Genentech has won the following awards for their Diversity and Inclusion efforts:


 * Forbes named Genentech one of “America's Best Employers for Diversity”
 * Forbes named Genentech one of “America’s Best Large Employers”
 * Human Rights Campaign Diversity scoring Genentech 100 on the “Corporate Equality Index”

Their 2025 diversity and inclusion commitments include doubling the number of Black/African American and Hispanic/Latinx representation at the director and extended leadership levels.